Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Assertio Holdings Inc ASRT

Healthcare Drug Manufacturers - Specialty & Generic
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also... see more

Current News (NDAQ:ASRT)

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Business Wire 4 days ago

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

Business Wire 7 days ago

Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

Business Wire December 22, 2025

Assertio Reports Third Quarter 2025 Financial Results

Business Wire November 10, 2025

Assertio Announces Leadership Transition

GlobeNewswire October 28, 2025

CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025

PR Newswire September 23, 2025

Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 3-DAY DEADLINE in Securities Lawsuit- Hagens Berman

GlobeNewswire September 21, 2025

DEADLINE NEXT WEEK: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Contact the Firm Before September 24, 2025

GlobeNewswire September 18, 2025

Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

GlobeNewswire September 15, 2025
View More News ››

Opinion & Analysis (NDAQ:ASRT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ASRT)

Q2 results…SOLID RESULTS!!!

https://www.globenewswire.com/news-release/2022/08/08/2493714/0/en/Assertio-Reports-Second-Quarter-2022-Financial-Results.html
MB11111 - August 8, 2022

52 week high today!

Good sign for Q2 results on Aug 8th!
MB11111 - July 28, 2022

Q2 release August 8th

https://www.stck.pro/news/ASRT
MB11111 - July 26, 2022

Promising future

Been here since Nov 2021 and doubled my investment so far but still no posting! 
MB11111 - April 1, 2022

New here

Latest financial results look promising.  Just started a small position.  Any insights let me know! glta
MB11111 - November 9, 2021

My friend Anna recommended this to me.

Doing my on DD, checking it out before investing.
Oasisjunior - February 18, 2021
View more Bullboard ››

AJA Health and Wellness Inc

AJA Health and Wellness Inc

AJA Health and Wellness Inc. operates a telemedicine platform and full-service travel clinics. The company offers virtual ...
View More »

Podcasts